Literature DB >> 20662730

Association of the renin gene polymorphism, three angiotensinogen gene polymorphisms and the haplotypes with essential hypertension in the Mongolian population.

Chang-Qing Ying1, Yan-Hua Wang, Zheng-Lai Wu, Ming-Wu Fang, Jian Wang, Yong-Shan Li, Yong-Hong Zhang, Chang-Chun Qiu.   

Abstract

Renin is a rate-limiting enzyme of the renin-angiotensin system and plays a crucial role in the regulation of blood pressure (BP). Angiotensinogen (AGT) is the precursor of potent vasoactive hormone angiotensin II and the AGT gene has been incriminated as a marker for genetic predisposition to essential hypertension (EH) in some ethnic groups. The purpose of the study is to explore the association of a new genetic marker of renin gene, and AGT gene M235T, A-6G, and A-20C polymorphisms and their haplotypes with EH in the Mongolian population. On the basis of the prevalence survey, 243 hypertensives and 258 normotensives who had no blood relationship with each other were selected as subjects. All the subjects were interviewed with questionnaires and their blood specimens were collected. Renin gene insertion/ deletion (I/D) polymorphism was genotyped by PCR-polyacrylamide gel electrophoresis. AGT gene M235T, A-6G, and A-20C polymorphisms were genotyped by a PCR-restriction fragment length polymorphism and single-strand conformation polymorphism. The frequencies of renin genotype DD and allele D in hypertensives (36.21%, 63.79%, respectively) were significantly higher than those in normotensives (29.84%, 57.17%, respectively, P < 0.05). The odds ratios (OR) of renin genotype ID, DD to renin genotype II on hypertension were 1.98 (OR 95% CI 1.08-3.72) and 2.51 (OR 95% CI 1.33-4.88), respectively. There were no significant differences in the distributions of genotypes and alleles for AGT gene M235T, A-6G, and A-20C polymorphisms and all different haplotypes between the two groups. Renin gene I/D polymorphism is associated with EH, whereas AGT gene M235T, A-6G, and A-20C polymorphisms and the haplotypes are not associated with EH in the Mongolian population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20662730     DOI: 10.3109/10641960903443517

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  6 in total

1.  Case-control association study of polymorphisms in the angiotensinogen and angiotensin-converting enzyme genes and coronary artery disease and systemic artery hypertension in African-Brazilians and Caucasian-Brazilians.

Authors:  Ricardo Bonfim-Silva; Larissa Oliveira Guimarães; Jandson Souza Santos; Jaqueline Fagundes Pereira; Ana Angélica Leal Barbosa; Domingos Lazaro Souza Rios
Journal:  J Genet       Date:  2016-03       Impact factor: 1.166

Review 2.  Genetics of Human Primary Hypertension: Focus on Hormonal Mechanisms.

Authors:  Worapaka Manosroi; Gordon H Williams
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

3.  GLAD4U: deriving and prioritizing gene lists from PubMed literature.

Authors:  Jérôme Jourquin; Dexter Duncan; Zhiao Shi; Bing Zhang
Journal:  BMC Genomics       Date:  2012-12-17       Impact factor: 3.969

4.  A-6G and A-20C polymorphisms in the angiotensinogen promoter and hypertension risk in Chinese: a meta-analysis.

Authors:  Wei Gu; Jielin Liu; Qiuli Niu; Hao Wang; Yuqing Lou; Kuo Liu; Lijuan Wang; Zuoguang Wang; Jingmei Zhang; Shaojun Wen
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

5.  A polymorphism of the renin gene rs6682082 is associated with essential hypertension risk and blood pressure levels in Korean women.

Authors:  Jongkeun Park; Kijun Song; Yangsoo Jang; Sungjoo Kim Yoon
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

6.  Haplotype-based association of renin gene polymorphisms with essential hypertension in Han population of northern china.

Authors:  Guoping Zhang; Xueyan Li; Keyong Zhang; Jingbo Zhao; Changchun Qiu
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Oct-Dec       Impact factor: 1.636

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.